Woodside Energy Group Ltd
WDS
Westpac Banking Corp
WBC
Telstra Group Ltd
TLS
4
Rio Tinto Ltd
RIO
5
Origin Energy Ltd
ORG
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.